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Currently, drug discovery technology is heavily dependent on
combinatorial chemistry and high throughput screening, re-
sulting in more and more poorly water-soluble drugs, either
class II (low solubility and high permeability) or IV (low solu-
bility and low permeability) in the standard biopharmaceutical
classification system. Owing to the importance of solubility/
dissolution for oral absorption, formulation scientists face a
great challenge.Thus, strategies have been proposed to improve
the solubility and dissolution rate. Among these approaches,
solid dispersion [1] and nanosuspension [2] are themost usually
used. However, which one is better for improving the in vitro
dissolution and in vivo bioavailability? Some experts have
already asked this question and made some efforts to answer
it. However, the research carried out to date has involved a
limited number of model compounds [3].
The aim of this research is to give a comparison, in terms
of the in vitro dissolution and in vivo pharmacokinetics, of solid
dispersion and nanocrystals, with different substances
(lacidipine,itraconazole, nimodipine, ziprasidone, and etc.) as
model compounds.The data are mainly summarized from pre-
vious research in our group.The solid dispersions were prepared
by the melting method or the solvent method, while the
nanocrystals were obtained by media milling or high pres-
sure homogenization. Then, they were characterized by PSD,
TEM, DSC, XRD, FTIR, and SEM analysis. Finally, the pharma-
cokinetic study was carried out in beagle dogs. We found, in
most cases, that solid dispersion exhibited higher dissolu-
tion profile, while nanocrystals produced the greater increase
in oral bioavailability. More importantly, the in vivo pharma-
cokinetic results did not agree with the in vitro dissolution
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profiles. In addition, data in the literatures were also re-
viewed to support our viewpoint.The results here demonstrate
that the use of in vitro dissolution tests for the prediction of
in vivo behavior is of limited value for poorly water-soluble
drugs when giving comparisons of different formulation strat-
egies. The results obtained in this work will provide guidance
for the research and development of poorly water-soluble
drugs.
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Fig. 1 Illustration for the in vitro dissolution and in vivo pharmacokinetic profiles for different strategies (solid dispersion,
nanocrystals and micronization). Solid dispersion exhibited higher dissolution profile, while nanocrystals produced the greater
increase in oral bioavailability.
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